Question 1

What is Sol-Gel Technologies's P/S ratio?

Accepted Answer

Sol-Gel Technologies (SLGL) P/S ratio is 11.3× as of June 12, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Sol-Gel Technologies?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Sol-Gel Technologies specifically, the relevant sector benchmark is the current sector median of 3.7×.

Question 5

Is Sol-Gel Technologies's P/S ratio high or low?

Accepted Answer

Sol-Gel Technologies's P/S ratio of 11.3× is below its own 5-year average of 126.1× and above the sector median of 3.7×. That places the current reading at the 15th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Sol-Gel Technologies's historical P/S ratio range?

Accepted Answer

In the available daily series, Sol-Gel Technologies (SLGL) P/S ratio has ranged from a low of 1.8× in 2025 to a high of 14098.6× in 2017. The 5-year average is 126.1× and the 5-year median is 50.5×.

Question 7

What was Sol-Gel Technologies's P/S ratio in 2025?

Accepted Answer

Sol-Gel Technologies (SLGL) P/S ratio at the end of 2025 was 6.1×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Sol-Gel Technologies's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$117.40M	$19.39M	6.1×	-16.4×	Dec 31, 2025
2024	$259.08M	$11.54M	22.5×	-131.2×	Dec 31, 2024
2023	$309.22M	$2.01M	153.7×	-118.0×	Dec 31, 2023
2022	$1.05B	$3.88M	271.7×	+217.0×	Dec 31, 2022
2021	$1.71B	$31.27M	54.7×	-199.9×	Dec 31, 2021
2020	$2.23B	$8.77M	254.5×	+101.4×	Dec 31, 2020
2019	$3.51B	$22.90M	153.1×	-8690.2×	Dec 31, 2019
2018	$1.14B	$129.00K	8843.3×	-5255.3×	Dec 31, 2018
2017	$2.45B	$174.00K	14098.6×	—	Dec 31, 2017
2016	$2.45B	$0.00	—	—	Dec 31, 2016


AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Teladoc Health (TDOC)	0.4×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Sol-Gel Technologies (SLGL)

P/S Ratio daily chart for Sol-Gel Technologies (SLGL)

Historical P/S Ratio for Sol-Gel Technologies (SLGL) from 2016 to 2025

About P/S Ratio at Sol-Gel Technologies (SLGL)

Sol-Gel Technologies P/S Ratio by Year

Sol-Gel Technologies P/S Ratio 2025: 6.1×

Sol-Gel Technologies P/S Ratio 2024: 22.5×

Sol-Gel Technologies P/S Ratio 2023: 153.7×

Sol-Gel Technologies P/S Ratio 2022: 271.7×

Sol-Gel Technologies P/S Ratio 2021: 54.7×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Sol-Gel Technologies (SLGL) Key Financials

P/S Ratio daily chart for Sol-Gel Technologies (SLGL)

Historical P/S Ratio for Sol-Gel Technologies (SLGL) from 2016 to 2025

About P/S Ratio at Sol-Gel Technologies (SLGL)

Sol-Gel Technologies P/S Ratio by Year

Sol-Gel Technologies P/S Ratio 2025: 6.1×

Sol-Gel Technologies P/S Ratio 2024: 22.5×

Sol-Gel Technologies P/S Ratio 2023: 153.7×

Sol-Gel Technologies P/S Ratio 2022: 271.7×

Sol-Gel Technologies P/S Ratio 2021: 54.7×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is Sol-Gel Technologies's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for Sol-Gel Technologies?

+Is Sol-Gel Technologies's P/S ratio high or low?

+What is Sol-Gel Technologies's historical P/S ratio range?

+What was Sol-Gel Technologies's P/S ratio in 2025?

+Why does Sol-Gel Technologies's P/S ratio change over time?

Sol-Gel Technologies (SLGL) Key Financials